Cargando…
Identification of serious, unpredictable adverse events with tocilizumab
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366479/ http://dx.doi.org/10.1007/s40278-020-80763-1 |
Ejemplares similares
-
Remdesivir vs tocilizumab in COVID-19: adverse event profiles
Publicado: (2021) -
Ad26.COV2.S COVID-19 vaccine: TTS a rare, but serious adverse event
Publicado: (2022) -
Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients: Nivolumab-related serious/fatal adverse events
por: Zhao, Bin, et al.
Publicado: (2018) -
Design of the Tocilizumab in Giant Cell Arteritis Trial
por: Unizony, Sebastian H., et al.
Publicado: (2013) -
A case of serious laryngeal edema unpredictably detected during laryngoscopy for orotracheal intubation following induction of anesthesia
por: Koga, Yukari, et al.
Publicado: (2011)